drugset / Trial / NCT03477487
Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain
Non-randomizedSequentialOpen-labelTreatment
Summary
Evaluation of Safety, Tolerability, and Efficacy of XT-150, a plasmid DNA with a variant of human IL-10 transgene. XT-150 will be a single injection into the knee synovial capsule for the Treatment of Osteoarthritic Pain.
Timeline
- Start
- 2018-06-08
- Primary completion
- 2019-07-19
- Completion
- 2019-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XT-150 | Other / unclassified | — | Other |